Florida Hospital

AdventHealth.com

This is whole-person care. And we’re coming together under one unified name to heal what hurts, ease your mind, and lift your spirit. The same doctors you know, the same care you trust, and the same level of compassion you’ve always felt. Soon, we’ll be caring for your whole health as AdventHealth. We are elevating the standard of your care with our connected network of world-class experts, the latest technology, and locations close to home. No matter where you are in life, you and your family are covered from head to toe with heart-to-heart care every step of the way.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Pharma Tech

PATIENTS WITH SERIOUS OPHTHALMOLOGIC CONDITIONS HAVE ACCESS TO PHOSPHOLINE IODIDE®

AllianceRx Walgreens Pharmacy | September 28, 2022

news image

AllianceRx Walgreens Pharmacy has received exclusive access to Phospholine Iodide® from Fera Pharmaceuticals. Phospholine Iodide is used to help reduce elevated intraocular pressure of glaucoma and for accommodative esotropia in children. "AllianceRx Walgreens Pharmacy is excited to be able to offer this invaluable therapeutic option to help correct these chronic and rare ophthalmologic conditions. These patients deserve access to this life-changing ...

Read More

Business Insights

SIGNET HEALTHCARE PARTNERS COMPLETES GROWTH EQUITY INVESTMENT IN JUNO PHARMACEUTICALS CORP

Juno Pharmaceuticals | February 25, 2022

news image

Juno Pharmaceuticals Corp a Canadian specialty generics pharmaceuticals company, announced that it has received a strategic growth investment from Signet Healthcare Partners (“Signet”), a New York-based healthcare growth equity firm. Juno intends to use these proceeds to expand its complex and high-value generic and biosimilar portfolio and to accelerate growth. “We are very pleased with the opportunity to partner with the Juno management te...

Read More

Business Insights

ACTINIUM PHARMACEUTICALS, INC. AND IMMEDICA HAVE SIGNED A COMMERCIALIZATION AGREEMENT FOR IOMAB-B (131I APAMISTAMAB)APAMISTAMAB)

Actinium Pharmaceuticals, Inc. | April 13, 2022

news image

Actinium Pharmaceuticals, Inc., a leader developing targeted radiotherapies for patients and Immedica Pharma AB announced that they signed a license and supply agreement for Iomab-B. It is being developed for targeted conditioning to facilitate bone marrow with topline data expected in the third quarter of 2022. For individuals with active, relapsed, or refractory acute myeloid leukemia, BMT is the only possibly curative therapy option. "Immedica has est...

Read More

Business Insights, PHARMA TECH

THERMO FISHER SCIENTIFIC’S ADVANCED ANALYTICAL INSTRUMENTS RECEIVE R&D 100 AWARDS

Thermo Fisher Scientific | December 19, 2022

news image

Thermo Fisher Scientific Inc., the world leader in serving science, received R&D 100 Awards from R&D World Magazine for two of its most recently launched analytical instruments. The R&D 100 Awards competition honors the latest innovations in science and technology, identifying the top 100 revolutionary technologies of the past year. The Thermo Scientific Gallery Enzyme Master Enzyme Analyzer was recognized as an R&D 100 Award winner in the Analytical/Test category....

Read More
news image

Pharma Tech

PATIENTS WITH SERIOUS OPHTHALMOLOGIC CONDITIONS HAVE ACCESS TO PHOSPHOLINE IODIDE®

AllianceRx Walgreens Pharmacy | September 28, 2022

AllianceRx Walgreens Pharmacy has received exclusive access to Phospholine Iodide® from Fera Pharmaceuticals. Phospholine Iodide is used to help reduce elevated intraocular pressure of glaucoma and for accommodative esotropia in children. "AllianceRx Walgreens Pharmacy is excited to be able to offer this invaluable therapeutic option to help correct these chronic and rare ophthalmologic conditions. These patients deserve access to this life-changing ...

Read More
news image

Business Insights

SIGNET HEALTHCARE PARTNERS COMPLETES GROWTH EQUITY INVESTMENT IN JUNO PHARMACEUTICALS CORP

Juno Pharmaceuticals | February 25, 2022

Juno Pharmaceuticals Corp a Canadian specialty generics pharmaceuticals company, announced that it has received a strategic growth investment from Signet Healthcare Partners (“Signet”), a New York-based healthcare growth equity firm. Juno intends to use these proceeds to expand its complex and high-value generic and biosimilar portfolio and to accelerate growth. “We are very pleased with the opportunity to partner with the Juno management te...

Read More
news image

Business Insights

ACTINIUM PHARMACEUTICALS, INC. AND IMMEDICA HAVE SIGNED A COMMERCIALIZATION AGREEMENT FOR IOMAB-B (131I APAMISTAMAB)APAMISTAMAB)

Actinium Pharmaceuticals, Inc. | April 13, 2022

Actinium Pharmaceuticals, Inc., a leader developing targeted radiotherapies for patients and Immedica Pharma AB announced that they signed a license and supply agreement for Iomab-B. It is being developed for targeted conditioning to facilitate bone marrow with topline data expected in the third quarter of 2022. For individuals with active, relapsed, or refractory acute myeloid leukemia, BMT is the only possibly curative therapy option. "Immedica has est...

Read More
news image

Business Insights, PHARMA TECH

THERMO FISHER SCIENTIFIC’S ADVANCED ANALYTICAL INSTRUMENTS RECEIVE R&D 100 AWARDS

Thermo Fisher Scientific | December 19, 2022

Thermo Fisher Scientific Inc., the world leader in serving science, received R&D 100 Awards from R&D World Magazine for two of its most recently launched analytical instruments. The R&D 100 Awards competition honors the latest innovations in science and technology, identifying the top 100 revolutionary technologies of the past year. The Thermo Scientific Gallery Enzyme Master Enzyme Analyzer was recognized as an R&D 100 Award winner in the Analytical/Test category....

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us